Do you want to read an article? Please log in or register.
Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial
AsthmaCOPD
RECOMMENDED
Related content
COPD
Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Int J Chron Obstruct Pulmon Dis.
Beeh KM, Beier J, Candler H, Wittig T
doi: 10.2147/COPD.S11765
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M, INBUILD trial investigators.
doi: 10.1016/S2213-2600(20)30036-9.
RECOMMENDED
Further Publications
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Med.
Paoletti G, Keber E, Heffler E, Malipiero G, Baiardini I, Canonica GW, Giua C, SIFAC Group of Clinical community Pharmacists (SGCP).
doi: 10.1016/j.rmed.2020.106199.Visit the original publication at ncbi.nlm.nih.gov
RECOMMENDED
Interstitial Lung Disease
Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1186/s13063-020-4188-4.
AsthmaCOPD
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
Lancet Respir Med.
Bafadhel M, Peterson S, De Blas MA, Calverley PM, Rennard SI, Richter K, Fagerås M
doi: 10.1016/
RECOMMENDED
Interstitial Lung Disease
Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease - a randomised placebo-controlled trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Kronborg-White S, Andersen CU, Kohberg C, Hilberg O, Bendstrup E
doi: 10.1186/s12931-020-01452-7.
RECOMMENDED
COPD
Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Vogt S, Leuppi JD, Schuetz P, Mueller B, Volken C, Dräger S, Trendelenburg M, Rutishauser J, Osthoff M
doi: 10.1186/s12931-021-01822-9
RECOMMENDED
Pulmonary FibrosisRespiratory Tract InfectionFurther Publications
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
Lancet Respir Med.
Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA
doi: 10.1016/
RECOMMENDED
AsthmaCOPD
Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial
Respir Res.
Gregoriano C, Dieterle T, Breitenstein AL, Dürr S, Baum A, Maier S, Arnet I, Hersberger KE, Leuppi JD
doi: 10.1186/s12931-018-0936-3.